Advertisement
Screener

GLAUKOS Corp (GKOS) Graph

GKOS Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $185.61M; Cost of revenue $34.02M; Research and development (m); Selling, general and administrative $116.06M.
  • 2026-03-31: Revenue $150.57M; Cost of revenue $33.34M; Research and development (m); Selling, general and administrative $92.94M.
  • 2025-12-31: Revenue $143.12M*; Cost of revenue $31.77M*; Research and development (m); Selling, general and administrative $94.70M*.
  • 2025-09-30: Revenue $133.54M; Cost of revenue $28.83M; Research and development (m); Selling, general and administrative $83.00M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

GKOS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Corneal Health$30.43MGlaucoma$155.18MRevenue$185.61MCost of revenue$34.02MGross profit$151.59MOperating expenses$168.86MOperating income-$17.27MOther income, net-$1.27MSelling, general& administrative$116.06MPre-tax income-$17.72MNet income-$18.38M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

GKOS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$38.87MUS$146.74MRevenue$185.61MCost of revenue$34.02MGross profit$151.59MOperating expenses$168.86MOperating income-$17.27MOther income, net-$1.27MSelling, general& administrative$116.06MPre-tax income-$17.72MNet income-$18.38M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

GKOS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Development And CommercializationOf Ophthalmic Therapies$185.61MRevenue$185.61MCost of revenue$34.02MGross profit$151.59MOperating expenses$168.86MOperating income-$17.27MOther income, net-$1.27MSelling, general& administrative$116.06MPre-tax income-$17.72MNet income-$18.38M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$185.61M$34.02M(m)$116.06M$168.86M$656.00K-$18.38M
2026-03-31$150.57M$33.34M(m)$92.94M$137.09M$484.00K-$19.78M
2025-12-31$143.12M*$31.77M*(m)$94.70M*$138.35M*-$6.16M*-$133.66M*
2025-09-30$133.54M$28.83M(m)$83.00M$121.07M$234.00K-$16.23M
2025-06-30$124.12M$26.90M(m)$83.38M$119.91M$248.00K-$19.66M
2025-03-31$106.66M$24.32M(m)$70.67M$103.03M$326.00K-$18.15M
2024-09-30$96.67M$22.58M(m)$64.00M$98.75M$177.00K-$21.41M
2024-06-30$95.69M$22.55M(m)$66.19M$103.11M$331.00K-$50.55M
2024-03-31$85.62M$20.26M(m)$61.98M$104.43M$377.00K-$40.84M
2023-09-30$78.05M$18.51M(m)$54.25M$87.55M$37.00K-$30.44M
2023-06-30$80.40M$20.10M(m)$53.14M$89.37M$435.00K-$32.81M
2023-03-31$73.90M$18.07M(m)$53.65M$88.82M$401.00K-$34.63M
2022-12-31$71.23M$17.22M(m)$51.93M$87.74M$298.00K-$31.46M
2022-09-30$71.27M$16.86M(m)$47.15M$76.02M$247.00K-$27.58M
2022-06-30$72.69M$17.83M(m)$49.90M$91.61M-$105.00K-$45.54M
2022-03-31$67.68M$17.06M$26.88M$43.95M$40.83M$326.00K$5.38M
2021-12-31$73.24M$16.86M(m)$47.57M$74.24M-$363.00K-$21.87M
2021-09-30$74.71M$15.37M(m)$44.47M$48.32M$202.00K$6.23M
2021-06-30$78.09M$17.76M(m)$45.30M$74.56M$208.00K-$17.48M
2021-03-31$67.97M$16.63M$21.22M$41.92M$63.14M$279.00K-$16.47M
2020-12-31$73.23M$19.59M(m)$43.79M$65.04M-$3.24M-$10.65M
2020-09-30$64.83M$17.93M(m)$38.95M$59.25M-$889.00K-$15.75M
2020-06-30$31.56M$21.67M(m)$38.12M$57.09M-$7.38M-$39.89M
2020-03-31$55.34M$32.53M(m)$50.55M$75.42M-$450.00K-$54.06M
2019-12-31$65.85M$15.90M(m)$59.61M$79.64M-$65.84M$36.58M
2019-09-30$58.51M$7.70M(m)$44.44M$63.22M$187.00K-$13.51M
2019-06-30$58.60M$7.87M(m)$37.66M$56.97M$72.00K-$6.31M
2019-03-31$54.03M$7.11M$13.93M$34.92M$48.85M$122.00K-$1.34M
2018-12-31$54.08M$7.12M$12.96M$32.10M$45.06M$530.00K$1.78M
2018-09-30$43.91M$6.01M$13.20M$31.63M$44.83M$37.00K-$6.62M
2018-06-30$43.16M$6.16M$12.61M$28.64M$41.25M$11.00K-$5.40M
2018-03-31$40.13M$5.79M$10.91M$27.16M$38.06M$5.00K-$2.71M
2017-12-31$41.65M$4.63M$10.53M$25.96M$36.49M-$37.00K$1.01M
2017-09-30$40.41M$5.72M$9.80M$24.14M$33.95M$53.00K$1.32M
2017-06-30$41.28M$5.52M$9.63M$24.68M$39.63M$22.00K-$3.30M
2017-03-31$35.91M$5.18M$8.94M$21.48M$30.42M$55.00K$878.00K
2016-12-31(m)(m)$7.40M$20.49M$27.89M-$97.00K$134.00K
2016-09-30$29.58M(m)$7.81M$16.85M$24.66M$140.00K$1.16M
2016-06-30$28.56M(m)$6.96M$15.12M$22.07M$0.00$2.33M
2016-03-31$23.09M(m)$7.06M$12.29M$19.35M$0.00$897.00K
2015-12-31(m)(m)$6.29M$12.39M$18.69M$33.00K-$2.29M
2015-09-30$19.00M(m)$6.17M$11.24M$17.41M(m)-$2.06M
2015-06-30$17.75M(m)$7.34M$12.52M$19.86M(m)-$31.93M
2015-03-31$17.75M(m)$5.24M$7.82M$13.06M(m)-$966.00K
2014-12-31(m)(m)$5.31M$8.94M$14.24M$11.00K-$4.61M
2014-09-30$12.13M(m)$5.09M$6.67M$11.76M$5.00K-$1.49M
2014-06-30$11.10M(m)$4.42M$6.58M$11.00M(m)-$2.07M
2014-03-31(m)(m)$4.38M$5.95M$10.33M$2.00K-$3.96M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$336.18M$67.36M(m)$209.00M$305.95M$1.14M-$38.16M
2025-06-30$230.78M$51.21M(m)$154.05M$222.94M$574.00K-$37.80M
2024-06-30$181.31M$42.81M(m)$128.16M$207.54M$708.00K-$91.38M
2023-06-30$154.30M$38.17M(m)$106.79M$178.19M$836.00K-$67.44M
2022-06-30$140.37M$34.90M(m)$93.85M$132.44M$221.00K-$40.16M
2021-06-30$146.06M$34.39M(m)$87.22M$137.70M$487.00K-$33.95M
2020-06-30$86.89M$54.20M(m)$88.66M$132.51M-$7.83M-$93.95M
2019-06-30$112.63M$14.98M(m)$72.58M$105.83M$194.00K-$7.65M
2018-06-30$83.29M$11.95M(m)$55.79M$79.31M$16.00K-$8.11M
2017-06-30$77.19M$10.70M(m)$46.16M$70.05M$77.00K-$2.42M
2016-06-30$51.65M(m)$14.02M$27.41M$41.42M$0.00$3.23M
2015-06-30$32.42M(m)$12.58M$20.33M$32.91M(m)-$32.89M
2014-06-30$19.35M(m)$8.80M$12.53M$21.34M$2.00K-$6.03M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$364.32M$80.04M(m)$237.05M$344.01M$808.00K-$54.03M
2024-09-30$277.98M$65.39M(m)$192.16M$306.29M$885.00K-$112.79M
2023-09-30$232.35M$56.68M(m)$161.03M$265.74M$873.00K-$97.88M
2022-09-30$211.63M$51.76M(m)$141.00M$208.46M$468.00K-$67.73M
2021-09-30$220.77M$49.76M(m)$131.69M$186.01M$689.00K-$27.72M
2020-09-30$151.72M$72.13M(m)$127.61M$191.76M-$8.72M-$109.70M
2019-09-30$171.13M$22.68M(m)$117.02M$169.05M$381.00K-$21.16M
2018-09-30$127.20M$17.96M(m)$87.42M$124.14M$53.00K-$14.73M
2017-09-30$117.60M$16.42M(m)$70.30M$104.00M$130.00K-$1.10M
2016-09-30$81.22M(m)$21.82M$44.26M$66.09M$140.00K$4.39M
2015-09-30$51.42M(m)$18.75M$31.57M$50.32M(m)-$34.95M
2014-09-30$31.47M(m)$13.90M$19.20M$33.10M$7.00K-$7.52M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$507.44M$111.81M(m)$331.75M$482.36M-$5.35M-$187.69M
2024-12-31$383.48M$94.03M(m)$261.17M$411.82M$771.00K-$146.37M
2023-12-31$314.71M$75.58M(m)$224.07M$367.84M$934.00K-$134.66M
2022-12-31$282.86M$68.98M(m)$192.93M$296.20M$766.00K-$99.19M
2021-12-31$294.01M$66.63M(m)$179.26M$260.26M$326.00K-$49.59M
2020-12-31$224.96M$91.72M(m)$171.40M$256.79M-$11.97M-$120.35M
2019-12-31$236.98M$38.59M(m)$176.63M$248.69M-$65.46M$15.42M
2018-12-31$181.28M$25.07M$49.68M$119.53M$169.21M$583.00K-$12.95M
2017-12-31$159.25M$21.05M$38.91M$96.26M$140.49M$93.00K-$92.00K
2016-12-31$114.40M$16.18M$29.22M$64.76M$93.98M$43.00K$4.52M
2015-12-31$71.70M(m)$25.05M$43.96M$69.01M$33.00K-$37.24M
2014-12-31$45.59M(m)$19.20M$28.14M$47.34M$18.00K-$12.13M
2013-12-31$20.95M(m)$15.51M$17.10M$32.61M$6.00K-$12.64M

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSULET CORP (PODD)United States$9.420B28.12
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
Penumbra Inc (PEN)United States$12.596B77.33
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85